Skip to content

Unusual abacavir hypersensitivity reaction involving severe respiratory symptoms reported

Almost a third of Indian patients make changes to first-line treatment regimen because of side-effects or cost

Viral hepatitis in low and middle-income settings

HIV and hepatitis in non-injecting drug users

Increase ribavirin dose for better HCV treatment response in coinfected individuals, experts argue

HAART reduces liver-related death risk, but hepatitis C infection increases risk, Italian study finds

HIV/HCV coinfected patients have poorer immunologic response to HIV treatment

Evidence that non-B strains of HIV being transmitted in the UK

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease